BIOMEDICAL DETECTION DEVICES USING MAGNETIC BIOSENSORS
20180372728 ยท 2018-12-27
Inventors
Cpc classification
G01N35/0098
PHYSICS
G01R33/12
PHYSICS
G01N33/53
PHYSICS
G01R33/0213
PHYSICS
International classification
G01N33/53
PHYSICS
G01R33/02
PHYSICS
Abstract
A biomedical detection device includes a sample cell, an electromagnetic generating unit, a light source and a light detection unit. The sample cell can be filled with a liquid sample containing a detection object and a magnetic biosensor capable of combining the detection object to form a magnetic cluster. The electromagnetic generating unit is disposed at opposite two sides of the sample cell, and capable of generating an oscillating magnetic field of single frequency to drive motions of the magnetic biosensor and the magnetic cluster. The light source is disposed at a side of the sample cell, and capable of emitting light rays to pass through the liquid sample. The light detection unit is disposed at another side of the sample cell oppositely to the light source, and capable of outputting electrical signals based on a change of the light rays.
Claims
1. A biomedical detection device, comprising: a sample cell, filled with a liquid sample containing a detection object and a magnetic biosensor capable of combining the detection object to form a magnetic cluster; an electromagnetic generating unit, disposed at opposite two sides of the sample cell, and capable of generating an oscillating magnetic field of single frequency to drive motions of the magnetic biosensor and the magnetic cluster; a light source, disposed at a side of the sample cell, and capable of emitting light rays to pass through the liquid sample; and a light detection unit, disposed at another side of the sample cell oppositely to the light source, and capable of outputting electrical signals based on a change of the light rays caused by the motions of the magnetic biosensor and the magnetic cluster when the light rays pass through the liquid sample.
2. The biomedical detection device according to claim 1, a concentration of the magnetic biosensor in the liquid sample is 0.1-2000 g/mL.
3. The biomedical detection device according to claim 1, wherein the single frequency of the oscillating magnetic field is 1-500 Hz, and an intensity of the oscillating magnetic field is 1-100 mT.
4. The biomedical detection device according to claim 1, wherein a wavelength of the light ray emitted by the light source is under 650 nm.
5. The biomedical detection device according to claim 3, wherein the light source comprises a polarized laser.
6. The biomedical detection device according to claim 1, further comprising a digital signal processor, for controlling the electromagnetic generating unit to generate the oscillating magnetic field of the single frequency, and storing a reference aggregate signal of a frequency being two times of the single frequency of the oscillating magnetic field.
7. The biomedical detection device according to claim 6, further comprising a lock-in amplifier, connecting to the light detection unit and the digital signal processor, and for measuring the change of the electrical signal based on the reference aggregate signal.
8. The biomedical detection device according to claim 6, wherein the reference aggregate signal comprises an in-phase component and a quadrature component.
9. The biomedical detection device according to claim 1, wherein an amount of the detection object is proportional to a difference of the intensity change between the light ray passing through the magnetic cluster and uncombined the detection object and the magnetic biosensor.
Description
BRIEF DESCRIPTION OF THE DRAWINGS
[0010] The present application can be understood in more detail by reading the subsequent detailed description in conjunction with the examples and references made to the accompanying drawings, in which:
[0011]
[0012]
[0013]
[0014]
[0015]
[0016]
[0017]
DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0018] The present application may be embodied in various forms and the details of the preferred embodiments of the present application will be described in the subsequent content with reference to the accompanying drawings. The drawings (not to scale) show and depict only the preferred embodiments of the invention and shall not be considered as limitations to the scope of the present application. Modifications of the shape of the present application shall be considered to be within the spirit of the present application.
[0019]
[0020] The sample cell 100 has micro-fluidic channels formed on a horizontal direction, and a magnetic biosensor 106 can combine a detection object 107 contained in a liquid sample through the micro-fluidic channels to form a magnetic cluster. The DSP 104 can output an oscillating signal to allow the electromagnetic generating unit 101 generates an oscillating magnetic field, and magnetic force lines thereof penetrate the sample cell 100 in a substantially vertical manner. Light rays emitted by a light source 102 pass through the liquid sample in the sample cell 100 from top to bottom, and are received by a light detection unit 103.
[0021] In embodiments of the present application, a concentration of the magnetic biosensor 106 in the liquid sample is 0.1-2000 g/mL. The electromagnetic generating unit 101 is a pair of electromagnets, the single frequency of the oscillating magnetic field is 1-500 Hz, and an intensity of the oscillating magnetic field is 1-100 mT. A wavelength of the light rays emitted by the light source 102 is under 650 nm, and the light source 102 includes a polarized laser. The light detection unit 103 includes photodiodes, and electrical signals output by the light detection unit 103 are voltage signals.
[0022]
[0023]
[0024]
[0025]
[0026] Therefore, a result that the electrical signal change M2 is subtracted by the electrical change M1 (i.e. a difference between of the electrical signals based on the rotations of the magnetic cluster 108 and the magnetic biosensor 106) is proportional to an amount of the detection object 107 combining the magnetic biosensor 106, the amount of the objected to be detected 107 is represented as:
The amount of the detection object=(the electrical signal change M2the electrical signal change M1)/k2, wherein k2 is a constant corresponding to specific magnetic biosensor 106 and the detection object 107 (EQ. 1).
[0027] In order to detect the change of electrical signals output by the light detection unit 103, the lock-in amplifier 105 is used for calculating the change of the electrical signals.
m(t)=M.sub.ac+sin(wt) EQ. 2
[0028] When the oscillating magnetic field drives the magnetic biosensor 106 rotating, the electrical signal U.sub.in output by the light detection unit 103 is not an oscillating signal of single frequency, but consisting of multiple signals of a frequency being two times of the magnetic field frequency. The electrical signals U.sub.in output by the light detection unit 103 is represented as EQ. 3, wherein represents a phase difference between the magnetic field m(t) and the electrical signals U.sub.in output by the light detection unit 103, b.sub.0, b.sub.2, b.sub.4, b.sub.6 represent amplitudes of the frequency.
U.sub.in=b.sub.0+b.sub.2*sin(2wt+)+b.sub.4*sin(4wt+)+b.sub.6*sin(6wt+)+ . . . , EQ. 3
[0029] In order to obtain the change of the electrical signals U.sub.in output by the light detection unit 103, a reference aggregate signal is set in the DSP 104. As shown in
U.sub.sin.sub._.sub.ref=u.sub.2*sin(2wt|)|u.sub.4*sin(4wt|)|u.sub.6*sin(6wt|)| . . . , EQ. 4
U.sub.cos ref=u.sub.2*cos(2wt+)+u.sub.4*cos(4wt+)+u.sub.6*cos(6wt+)+ . . . , EQ. 5
[0030] The DSP 104 transmits the references in-phase U.sub.sin.sub._.sub.ref and quadrature U.sub.cos.sub._.sub.ref to the lock-in amplifier 105; the lock-in amplifier 105 multiplies the electrical signals U.sub.in output by the light detection unit 103 with the reference U.sub.sin.sub._.sub.ref, and removes alternating current (AC) signal and retains the DC signal through integration; and an obtained DC signal is U.sub.In-Phase (in-Phase component) represented as EQ. 6, wherein constant k is related to a time length of the integration.
[0031] Same as the calculation of U.sub.In-Phase, the lock-in amplifier 105 multiplies the electrical signals U.sub.in output by the light detection unit 103 with the reference U.sub.cos ref, and removes alternating current (AC) signal and retains the DC signal through integration; and an obtained DC signal is U.sub.quadrature (quadrature component) represented as EQ. 7, wherein constant k is related to a time length of the integration.
[0032] Due both in-Phase component of EQ. 6 and quadrature component of EQ. 7 are related to the phase and the phase , effects of the phase and the phase can be removed by using EQ. 8, the obtained result is only related to the constants of the aggregate reference signal and the change of the electrical signals of the light detection unit 103. When the selected constants u.sub.2, u.sub.4, u.sub.6 of the aggregate reference signal are fixed, the obtained result is only related to the change M of the electrical signals U.sub.in output by the light detection unit 103; accordingly, the amount of the detection object 107 in the liquid sample can rapidly and accurately be obtained through calculation.
Change of the electrical signals
[0033] In an embodiment, the detection object is biotinylated anti-streptavidin, a biosensor having a combining uniqueness to the detection object is streptavidin. The biosensor streptavidin is a 60 kDa protein from Streptomycetes avidinii, contains four biotin-binding sites, and can be covalently coupled to the surface of specific magnetic nanoparticles. The detection process includes following steps: adding magnetic nanoparticles of a radius about 50 nm into a solution containing the streptavidin concentration of 500 ug/mL, allowing the streptavidin coating over the magnetic nanoparticles to form a magnetic biosensor solution; respectively mixing samples of 50 uL containing the biotinylated anti-streptavidin of concentrations in a range of 30-500 pM with the magnetic biosensor solution of 50 uL, disposing the mixed sample of 100 uL in the sample cell; reading a change of light rays of a laser (wavelength of 405 nm and intensity of 1 mw) passing through the mixed sample under a magnetic field (intensity of 2 mt and oscillating frequency of 20 Hz); then, driving movement of the magnetic biosensors in the mixed sample by using a stronger magnetic field (intensity of 80 mt), to allow the detection object biotinylated anti-streptavidin completely bonding to the streptavidin of the magnetic sensors, then, reading a change of light rays of the same laser passing through the mixed sample affected by the strong magnetic field; and, calculating the amounts of the detection objection biotinylated anti-streptavidin in each the mixed sample.
[0034]
[0035] In summary, in the biomedical detection device of the present application, the magnetic biosensor can combine the detection object to form the magnetic cluster, the electromagnetic generating unit can generate an oscillating magnetic field of single frequency to drive motions of the magnetic biosensor and the magnetic cluster, the light detection unit can output electrical signals based on a change of the light rays caused by motions of the magnetic biosensor and the magnetic cluster, when the light rays pass through the liquid sample, and the amount of the detection object in the liquid sample can rapidly and accurately be obtained through calculation of the change of the electrical signals output by the light detection unit.
[0036] Although the present application has been described with reference to the preferred embodiments, it will be understood that the invention is not limited to the details described thereof. Various substitutions and modifications have been suggested in the foregoing description, and others will occur to those of ordinary skill in the art. Therefore, all such substitutions and modifications are intended to be embraced within the scope of the invention as defined in the appended claims.